Clinical Trial Update: Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 single ascending dose study in healthy participants to assess safety, tolerability, and pharmacokinetics of long-acting injectable MMV055 alone and in c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• MMV055
• MMV371

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria, Falciparum | Phase 1 | Status: RECRUITING